chr11-61132386-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017966.5(VPS37C):c.502G>A(p.Gly168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000574 in 1,602,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017966.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS37C | NM_017966.5 | c.502G>A | p.Gly168Ser | missense_variant | 5/5 | ENST00000301765.10 | NP_060436.4 | |
VPS37C | XM_005274077.4 | c.502G>A | p.Gly168Ser | missense_variant | 5/5 | XP_005274134.1 | ||
VPS37C | XM_047427178.1 | c.*143G>A | 3_prime_UTR_variant | 5/5 | XP_047283134.1 | |||
VPS37C | XM_047427179.1 | c.*143G>A | 3_prime_UTR_variant | 5/5 | XP_047283135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS37C | ENST00000301765.10 | c.502G>A | p.Gly168Ser | missense_variant | 5/5 | 1 | NM_017966.5 | ENSP00000301765.5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 25AN: 224138Hom.: 0 AF XY: 0.000164 AC XY: 20AN XY: 122312
GnomAD4 exome AF: 0.0000627 AC: 91AN: 1450748Hom.: 0 Cov.: 34 AF XY: 0.0000860 AC XY: 62AN XY: 720838
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.502G>A (p.G168S) alteration is located in exon 5 (coding exon 4) of the VPS37C gene. This alteration results from a G to A substitution at nucleotide position 502, causing the glycine (G) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at